Bernard Taverne, Alice Desclaux, Papa Salif Sow

CHAPITRE II-1Diabète et hypertension artérielle : prévalence et facteurs associésird-00718213, version 1 - 16 Jul 201227. Goulet JL, Fultz SL, Rimland D, Butt A, Gibert C, Rodriguez-Barradas M, et al. Aging and infectious diseases: do patterns ofcomorbidity vary by HIV status, age, and HIV severity? Clin InfectDis. 2007 Dec 15;45(12):1593-601.28. Gress RE, Deeks SG. Reduced thymus activity and infectionprematurely age the immune system. J Clin Invest. 2009Oct;119(10):2884-7.29. Kirk JB, Goetz MB. Human immunodeficiency virus in an agingpopulation, a complication of success. J Am Geriatr Soc2009;57:2129-38.30. Zannou DM, Denoeud L, Lacombe K, Amoussou-Guenou D,Bashi J, Akakpo J, et al. Incidence of lipodystrophy and metabolicdisorders in patients starting non-nucleoside reverse transcriptaseinhibitors in Benin. Antiviral Therapy 2009, 14:371-380.31. Julius H, Basu D, Ricci E, Wing J, Basu JK, Pocaterra D, et al.The burden of metabolic diseases amongst HIV positive patientson HAART attending The Johannesburg Hospital. Curr HIV Res.2011 Jun 1;9(4):247-52.32. Cahn P, Leite O, Rosales A, Cabello R, Alvarez CA, Seas C, etal. Metabolic profile and cardiovascular risk factors among LatinAmerican HIV-infected patients receiving HAART. Braz J InfectDis. 2010 Mar-Apr;14(2):158-66.33. Bedimo R, Westfall AO, Mugavero M, Drechsler H, Khanna N,Saag M. Hepatitis C virus coinfection and the risk of cardiovasculardisease among HIV-infected patients.. HIV Med. 2010Aug;11(7):462-8.34. Tien PC, Schneider MF, Cole SR, Levine AM, Cohen M, DeHovitzJ, et al. Antiretroviral therapy exposure and incidence of diabetesmellitus in the Women's Interagency HIV Study. AIDS. 2007Aug 20;21(13):1739-45.35. Brown T.T., Cole S.R., Li X., Kingsley L.A., Palella F.J., RiddlerS.A., et al. Antiretroviral therapy and the prevalence and incidenceof diabetes mellitus in the multicenter AIDS cohort study. Arch.Intern. Med. 2005 ; 165 : 1179-1184.36. Da Silva EF, Bassichetto KC, Lewi DS. Lipid profile, cardiovascularrisk factors and metabolic syndrome in a group of AIDSpatients. Arq Bras Cardiol 2009 Aug;93(2):113-837. Howard AA, Floris-Moore M, Arnsten JH, Santoro N, FleischerN, Lo Y, et al. Disorders of glucose metabolism among HIV-infectedwomen. Clin Infect Dis. 2005 May 15;40(10):1492-9.38. González-Tomé MI, Ramos Amador JT, Guillen S, Solís I,Fernández-Ibieta M, Muñoz E, et al. Gestational diabetes mellitusin a cohort of HIV-1 infected women. HIV Med. 2008Nov;9(10):868-74.39. Wand H, Calmy A, Carey DL, Samaras K, Carr A, Law MG, etal on behalf of the INITION International Coordinating Committee.Metabolic Syndrome, cardiovascular disease and type 2 diabetesmellitus after initiation of antiretroviral therapy in HIV infection.AIDS 2007; 21:2445-53.40. Jain MK, Aragaki C, Fischbach L, Gibson S, Arora R, May L, etal. Hepatitis C is associated with type 2 diabetes mellitus in HIV-infectedpersons without traditional risk factors. HIV Med. 2007Nov;8(8):491-7.41. Ledergerber B., Furrer H., Rickenbach M., Lehmann R., Elzi L.,Hirschel B., et al. Factors associated with the incidence of type 2diabetes mellitus in HIV-infected participants in the Swiss HIVCohort Study. Clin. Infect. Dis. 2007 ; 45 : 111-119.42. Howard AA, Floris-Moore M, Lo Y, Arnsten JH, Fleischer N,Klein RS. Abnormal glucose metabolism among older men with orat risk of HIV infection. HIV Med. 2006 Sep;7(6):389-96.43. Butt AA, Fultz SL, Kwoh CK, Kelley D, Skanderson M, JusticeAC. Risk of diabetes in HIV infected veterans pre- andpost-HAART and the role of HCV coinfection. Hepatology. 2004Jul;40(1):115-9.44. Howard AA, Klein RS, Schoenbaum EE. Association of hepatitisC infection and antiretroviral use with diabetes mellitus in drugusers. Clin Infect Dis. 2003 May 15;36(10):1318-23. Epub 2003May 8.45. Saves M., Raffi F., Capeau J., Rozenbaum W., Ragnaud J.M.,Perronne C., et al. Factors related to lipodystrophy and metabolicalterations in patients with human immunodeficiency virus infectionreceiving highly active antiretroviral therapy. Clin. Infect. Dis. 2002; 34 : 1396-1405.46. De Wit S., Sabin C.A., Weber R., Worm S.W., Reiss P.,Cazanave C., et al. Incidence and risk factors for new-onset diabetesin HIV-infected patients: the Data Collection on Adverse Eventsof Anti-HIV Drugs (D:A:D) study. Diabetes Care 2008; 31: 1224-1229.47. Capeau J, Bouteloup V, Katlama C, Bastard JP, Guiyedi V,Salmon-Ceron D, Protopopescu C, Leport C, Raffi F, Chêne G;ANRS CO8 APROCO-COPILOTE Cohort Study Group. Ten-yeardiabetes incidence in 1046 HIV-infected patients started on acombination antiretroviral treatment. AIDS. 2012 Jan28;26(3):303-14.48. Arruda Junior ER, Lacerda HR, Moura LC, Albuquerque Mde F,Miranda Filho Dde B, Diniz GT, et al. Risk factors related to hypertensionamong patients in a cohort living with HIV/AIDS. Braz JInfect Dis. 2010 May-Jun;14(3):281-7.49. Mothe B, Perez I, Domingo P, Podzamczer D, Ribera E, CurranA, et al. HIV-1 infection in subjects older than 70: a multicentercross-sectional assessment in Catalonia, Spain. Curr HIV Res.2009 Nov;7(6):597-600.50. Baekken M, Os I, Sandvik L, Oektedalen O. Hypertension in anurban HIV-positive population compared with the general population:influence of combination antiretroviral therapy. J Hypertens.2008 Nov;26(11):2126-33.51. Palacios R, Santos J, García A, Castells E, González M, RuizJ, Márquez M. Impact of highly active antiretroviral therapy onblood pressure in HIV-infected patients. A prospective study in acohort of naive patients. HIV Med. 2006 Jan;7(1):10-5.52. Bergersen BM, Sandvik L, Dunlop O, Birkeland K, Bruun JN.Prevalence of hypertension in HIV-positive patients on highlyactive retroviral therapy (HAART) compared with HAART-naïveand HIV-negative controls: results from a Norwegian study of 721patients. Eur J Clin Microbiol Infect Dis. 2003 Dec;22(12):731-6.53. Gazzaruso C, Bruno R, Garzaniti A, Giordanetti S, Fratino P,Sacchi P, et al. Hypertension among HIV patients: prevalence andrelationships to insulin resistance and metabolic syndrome. JHypertens. 2003 Jul;21(7):1377-82.54. Coloma Conde AG, Alvarez Albarrán M, Roca-Cusachs Coll A,Domingo Pedrol P, Puig Campmany M. [Prevalence of arterialhypertension and lipid profile in HIV patients] Spanish. Med Clin(Barc). 2008 Nov 22;131(18):681-4.55. Grandominico JM, Fichtenbaum CJ. Short-term effect ofHAART on blood pressure in HIV-infected individuals. HIV ClinTrials. 2008 Jan-Feb;9(1):52-60.64